Patent Policy in Genomics and Human Genetics: A Public Health Perspective

Katerina Sideri
Publication date: 
Tue, 5 May 2015

This report presents the findings of a workshop in which key figures from the UK Department of Health, academic experts, and lawyers discussed the patenting of human DNA sequencing, to find the best balance between developing incentives for commercial research and development, whilst safeguarding tangible benefits to public health services. 
The report makes eight proposals covering issues including the 100,000 Genomes Project and the Health and Social Care Act, which allows the collection and sharing with commercial organizations of confidential information from medical records.